Key Takeaways
- • Ares Management (NYSE: ARES) closed at $126.51 on July 24, 2026, up $5.23 (+4.31%) in intraday trading, with analyst upside potential of +11.76% based on current price targets.
- • Oppenheimer maintained an "Outperform" rating on July 17, 2026, but lowered its price target from $146 to $140, reflecting modest compression in valuation expectations.
- • The stock has demonstrated volatility within a 52-week range of $95.80 to $195.26, indicating significant institutional trading activity and sentiment shifts throughout the period.
- • Publisher ratings indicate a "BUY" recommendation with an Investment Rating target of $139.00 and "High" ratings across both Industry and Management subrategories, suggesting institutional confidence in management execution.
Summary
Ares Management Corporation, a major alternative asset manager trading on the New York Stock Exchange under the ticker ARES, closed trading on July 24, 2026, at $126.51 per share, representing a gain of $5.23 or 4.31% from the previous market close. After-hours trading remained flat at $126.51 as of 7:51 PM EDT. The current price reflects an 11.76% upside potential relative to analyst consensus, indicating the market views the stock as trading below intrinsic value targets.
Analyst sentiment remains constructive despite recent price target reductions. Oppenheimer, a key institutional research provider, maintained its "Outperform" rating on the stock dated July 17, 2026, but lowered its 12-month price target from $146 to $140 per share. This modest downward revision suggests analyst confidence in the company's fundamentals while accounting for near-term macro headwinds or valuation normalization. Publisher-provided ratings assign the stock a "BUY" rating with a $139.00 target price, closely aligned with Oppenheimer's revised guidance, and maintain "High" subratings for both Industry relative strength and Management quality—a positive signal for institutional investors evaluating operational execution and competitive positioning.
The stock's 52-week trading range of $95.80 to $195.26 reflects meaningful volatility, with the current price positioned in the middle-to-lower range of that band. This price action is consistent with alternative asset managers navigating variable fundraising environments, fee pressure, and macroeconomic uncertainty. The intraday movement of 4.31% on July 24 suggests active institutional repositioning and retail interest, typical for large-cap alternative investment firms with substantial asset bases under management.
For hedge fund managers and family offices evaluating Ares as either a portfolio holding or as a competitive benchmark, the combination of "Outperform" analyst ratings, high management and industry subrategory scores, and modest upside to consensus targets presents a constructive but measured thesis. The recent price target compression warrants tracking management commentary on fundraising momentum, fee realization, and asset retention across its core business verticals in upcoming earnings or capital markets presentations.
Analyst sentiment remains constructive despite recent price target reductions. Oppenheimer, a key institutional research provider, maintained its "Outperform" rating on the stock dated July 17, 2026, but lowered its 12-month price target from $146 to $140 per share. This modest downward revision suggests analyst confidence in the company's fundamentals while accounting for near-term macro headwinds or valuation normalization. Publisher-provided ratings assign the stock a "BUY" rating with a $139.00 target price, closely aligned with Oppenheimer's revised guidance, and maintain "High" subratings for both Industry relative strength and Management quality—a positive signal for institutional investors evaluating operational execution and competitive positioning.
The stock's 52-week trading range of $95.80 to $195.26 reflects meaningful volatility, with the current price positioned in the middle-to-lower range of that band. This price action is consistent with alternative asset managers navigating variable fundraising environments, fee pressure, and macroeconomic uncertainty. The intraday movement of 4.31% on July 24 suggests active institutional repositioning and retail interest, typical for large-cap alternative investment firms with substantial asset bases under management.
For hedge fund managers and family offices evaluating Ares as either a portfolio holding or as a competitive benchmark, the combination of "Outperform" analyst ratings, high management and industry subrategory scores, and modest upside to consensus targets presents a constructive but measured thesis. The recent price target compression warrants tracking management commentary on fundraising momentum, fee realization, and asset retention across its core business verticals in upcoming earnings or capital markets presentations.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.